Rare Lymphomas

Rare Lymphomas

4.11 - 1251 ratings - Source

After a decade of tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma, optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist. This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity.Haematologica 94:1595a€“1598 Rashidi A, Lee ME, Fisher SI (2012) Hepatosplenic alphabeta T-cell lymphoma associated with azathioprine therapy. ... Am J Clin Pathol 102:310a€“315 Roulston D, LeBeau MM (1997) Cytogenetic analysis of hematologic malignant diseases. In: Barch MJ, Knutsen T, Spurbeck J (eds) The AGT cytogenetics laboratory manual. ... Elia A et al (2001) Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure.

Title:Rare Lymphomas
Author:Martin Dreyling, Michael E. Williams
Publisher:Springer Science & Business Media - 2014-02-13


You Must CONTINUE and create a free account to access unlimited downloads & streaming